2Albright F, Reifenstein EC Jr, Forbes AP. Effect of stilbestrol in post-menopausal osteoporosis[J]. Trans Conf Metab Asp Conval,1946(14) :99-101.
3Eriksen EF, Hodgson SF, Eastell R, et al. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation resorption, and bone loss at tissue and cellular levels[J]. J Bone Miner Res,1990,5(4) :311 -319.
4Gallagher JC. Role of estrogens in the management of poslraenopausalbone loss[J]. Rheum Dis Clin North Am, 2001,27(1) :143-162.
5Hikita A, Yana I, Wakeyama H, et al. Negative regulateon of osterclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand[J]. J Biol Chem,2006, 281(48) :36846-36855.
9Vural P, Akgul C,Canbaz M. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines andsome bone turnover markers in postmenopausal women[J]. Pharmacol Res, 2006,54 (4) : 296-302.
10Uemura H, Kamada M, Maegawa M, et al. Effect of hormone replacement therapy on the production of bone resorbing cytokines by peripheral blood cells in postmenopausal women[J]. Horm Metab Res, 2005,37 (4) 226-230.
